biote Corp.

NasdaqGM BTMD

biote Corp. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2024: USD 0.29

biote Corp. Dividend Per Share is USD 0.29 for the Trailing 12 Months (TTM) ending September 30, 2024, a -43.82% change year over year. Dividend per share represents the dividends distributed per share. Indicates dividend yield potential on a per-share basis.

biote Corp. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2023 was USD 0.51, a -63.54% change year over year.
biote Corp. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2022 was USD 1.40, a -47.65% change year over year.
biote Corp. Dividend Per Share for the Trailing 12 Months (TTM) ending September 30, 2021 was USD 2.67.

Key data

Date	Dividend Per Share	Free Cash Flow Per Share	Return on Assets (ROA)	Return on Equity (ROE)

NasdaqGM: BTMD

biote Corp.

CEO	Ms. Teresa S. Weber
IPO Date	April 28, 2021
Location	United States
Headquarters	1875 West Walnut Hill Lane
Employees	194
Sector	Health Care
Industries Pharmaceuticals Biotechnology Drugstores & Retail Pharmacies

Description

biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.

Key trends

Past 5 years